Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 2
2007 2
2008 4
2009 3
2010 4
2011 5
2012 5
2013 6
2014 10
2015 11
2016 9
2017 7
2018 4
2019 6
2020 7
2021 9
2022 6
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim YS, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr MB; MODIFY I and MODIFY II Investigators. Wilcox MH, et al. N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615. N Engl J Med. 2017. PMID: 28121498 Free article. Clinical Trial.
Delusional Infestation.
Laupland KB, Valiquette L. Laupland KB, et al. Among authors: valiquette l. Can J Infect Dis Med Microbiol. 2016;2016:9091838. doi: 10.1155/2016/9091838. Epub 2016 Mar 29. Can J Infect Dis Med Microbiol. 2016. PMID: 27366186 Free PMC article.
Get shorty!
Valiquette L, Laupland KB. Valiquette L, et al. Can J Infect Dis Med Microbiol. 2015 Jul-Aug;26(4):174-7. doi: 10.1155/2015/370240. Can J Infect Dis Med Microbiol. 2015. PMID: 26361482 Free PMC article. No abstract available.
Bezlotoxumab for the prevention of Clostridium difficile recurrence.
Couture-Cossette A, Carignan A, Ilangumaran S, Valiquette L. Couture-Cossette A, et al. Among authors: valiquette l. Expert Opin Biol Ther. 2017 Nov;17(11):1439-1445. doi: 10.1080/14712598.2017.1363886. Epub 2017 Aug 13. Expert Opin Biol Ther. 2017. PMID: 28805081 Review.
Looking beyond the laboratory is not preposterous.
Valiquette L, Laupland KB. Valiquette L, et al. J Assoc Med Microbiol Infect Dis Can. 2020 Mar 4;5(1):4-7. doi: 10.3138/jammi.2019-09-19. eCollection 2020 Mar. J Assoc Med Microbiol Infect Dis Can. 2020. PMID: 36339012 Free PMC article. No abstract available.
Ebola virus disease.
Laupland KB, Valiquette L. Laupland KB, et al. Among authors: valiquette l. Can J Infect Dis Med Microbiol. 2014 May;25(3):128-9. doi: 10.1155/2014/527378. Can J Infect Dis Med Microbiol. 2014. PMID: 25285105 Free PMC article. No abstract available.
10 years later..
Valiquette L, Laupland KB. Valiquette L, et al. Can J Infect Dis Med Microbiol. 2013 Winter;24(4):175-6. doi: 10.1155/2013/167289. Can J Infect Dis Med Microbiol. 2013. PMID: 24489556 Free PMC article. No abstract available.
Vaccine Effectiveness of non-adjuvanted and adjuvanted trivalent inactivated influenza vaccines in the prevention of influenza-related hospitalization in older adults: A pooled analysis from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN).
Pott H, Andrew MK, Shaffelburg Z, Nichols MK, Ye L, ElSherif M, Hatchette TF, LeBlanc J, Ambrose A, Boivin G, Bowie W, Johnstone J, Katz K, Lagacé-Wiens P, Loeb M, McCarthy A, McGeer A, Poirier A, Powis J, Richardson D, Semret M, Smith S, Smyth D, Stiver G, Trottier S, Valiquette L, Webster D, McNeil SA; Serious Outcomes Surveillance SOS Network of the Canadian Immunization Research Network CIRN; Toronto Invasive Bacterial Diseases Network TIBDN. Pott H, et al. Among authors: valiquette l. Vaccine. 2023 Oct 6;41(42):6359-6365. doi: 10.1016/j.vaccine.2023.08.070. Epub 2023 Sep 10. Vaccine. 2023. PMID: 37696717 Free article.
Leveraging Influenza Virus Surveillance From 2012 to 2015 to Characterize the Burden of Respiratory Syncytial Virus Disease in Canadian Adults ≥50 Years of Age Hospitalized With Acute Respiratory Illness.
ElSherif M, Andrew MK, Ye L, Ambrose A, Boivin G, Bowie W, David MP, Gruselle O, Halperin SA, Hatchette TF, Johnstone J, Katz K, Langley JM, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney JE, McGeer A, Poirier A, Pirçon JY, Powis J, Richardson D, Semret M, Smith S, Smyth D, Trottier S, Valiquette L, Webster D, McNeil SA, LeBlanc JJ; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN) and the Toronto Invasive Bacterial Diseases Network (TIBDN). ElSherif M, et al. Among authors: valiquette l. Open Forum Infect Dis. 2023 Jun 13;10(7):ofad315. doi: 10.1093/ofid/ofad315. eCollection 2023 Jul. Open Forum Infect Dis. 2023. PMID: 37441353 Free PMC article.
103 results